• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The role of oncostatin M in the pathogenesis of sarcopenia associated with chronic kidney disease

Research Project

Project/Area Number 18K08216
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 53040:Nephrology-related
Research InstitutionOsaka City University

Principal Investigator

Morioka Tomoaki  大阪市立大学, 大学院医学研究科, 准教授 (30382154)

Co-Investigator(Kenkyū-buntansha) 塩井 淳  大阪市立大学, 大学院看護学研究科, 教授 (90260801)
庄司 哲雄  大阪市立大学, 大学院医学研究科, 准教授 (40271192)
Project Period (FY) 2018-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Keywordsサルコペニア / オンコスタチンM / 骨格筋萎縮 / STAT3 / 慢性腎臓病 / C2C12細胞 / 腎不全 / アデニン負荷 / C/EBPδ
Outline of Final Research Achievements

In this study, we investigated the role of oncostatin M (OSM) in the pathogenesis of sarcopenia associated with chronic kidney disease. The mouse model of kidney failure induced by adenine exhibited reduced skeletal muscle mass with increased expression of OSM and OSM receptor and increased expression of genes associated with muscle degradation and growth inhibition. Next, in mature C2C12 myotubes treated with OSM in vitro, the myotube size was reduced, the expression of genes related to myogenic differentiation was decreased, while the expression of genes related to muscle degradation was increased. Furthermore, the effects of OSM on myotube size and changes in the gene expression were attenuated by pretreatment with an STAT3 inhibitor or siRNA-mediated STAT3 knockdown in C2C12 myotubes.
These results suggest that OSM contributes to muscle atrophy in chronic kidney disease by inhibiting myogenic differentiation and activating muscle degradation in a STAT3-dependent manner.

Academic Significance and Societal Importance of the Research Achievements

本研究により,炎症性サイトカインに属する多機能蛋白オンコスタチンMが慢性腎臓病に伴うサルコペニアに関与すること,またその機序の一部が細胞レベルで明らかになった.
慢性腎臓病患者の予後に関わるサルコペニアの機序としては,多様な要因が想定されている.今回,その一つとしてオンコスタチンMの役割が明らかになったことで,慢性腎臓病患者のサルコペニアを抑制し,予後改善につながる治療への発展が期待される.

Report

(5 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (11 results)

All 2020 2019 2018 Other

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (9 results) Remarks (1 results)

  • [Journal Article] Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation2019

    • Author(s)
      Miki Y, Morioka T, Shioi A, Fujimoto K, Sakura T, Uedono H, Kakutani Y, Ochi A, Mori K, Shoji T, Emoto M, Inaba M.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 516 Issue: 3 Pages: 951-956

    • DOI

      10.1016/j.bbrc.2019.06.143

    • NAID

      120006882169

    • URL

      https://ocu-omu.repo.nii.ac.jp/records/2019683

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] オンコスタチンMは腎不全に伴うサルコペニアに関与する2020

    • Author(s)
      三木祐哉,森岡与明,塩井 淳,佐倉剛史,角谷佳則,藤元健太,上殿英記,越智章展,森 克仁,庄司哲雄,稲葉雅章,絵本正憲
    • Organizer
      第65回日本透析医学会総会
    • Related Report
      2020 Research-status Report
  • [Presentation] オンコスタチンMはSTAT3経路を介して骨格筋萎縮に関与する2019

    • Author(s)
      三木祐哉、森岡与明、塩井淳、佐倉剛史、角谷佳則、藤元健太、上殿英記、森克仁、庄司哲雄、絵本正憲、稲葉雅章
    • Organizer
      第62回日本糖尿病学会年次学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 慢性腎臓病・糖尿病における骨格筋萎縮を考える2019

    • Author(s)
      森岡与明
    • Organizer
      第11回分子骨格筋代謝研究会
    • Related Report
      2019 Research-status Report
  • [Presentation] オンコスタチンMによるSTAT3経路を介した骨格筋萎縮への関与2019

    • Author(s)
      三木祐哉,森岡与明,塩井 淳,佐倉剛史,角谷佳則,藤元健太,上殿英記,森 克仁,庄司哲雄,絵本正憲,稲葉雅章
    • Organizer
      第40回日本肥満学会
    • Related Report
      2019 Research-status Report
  • [Presentation] Oncostatin M Inhibits C2C12 Myotube Formation through the STAT 3 Pathway2019

    • Author(s)
      YUYA MIKI, TOMOAKI MORIOKA, ATSUSHI SHIOI, TAKESHI SAKURA, KENTA FUJIMOTO, YOSHINORI KAKUTANI, HIDEKI UEDONO, KATSUHITO MORI, TETSUO SHOJI, MASANORI EMOTO, MASAAKI INABA
    • Organizer
      IDF Congress 2019 Busan
    • Related Report
      2019 Research-status Report
  • [Presentation] オンコスタチンMはSTAT3経路を介して骨格筋萎縮に関与する2019

    • Author(s)
      三木祐哉,森岡与明,塩井 淳,佐倉剛史,角谷佳則,藤元健太,上殿英記,森 克仁,庄司哲雄,絵本正憲,稲葉雅章
    • Organizer
      第62回日本糖尿病学会年次学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] オンコスタチンMはマウス筋管細胞の萎縮に関与する2018

    • Author(s)
      三木祐哉,森岡与明,佐倉剛史,角谷佳則,藤元健太,上殿英記,森 克仁,塩井 淳,庄司哲雄,絵本正憲,稲葉雅章
    • Organizer
      第61回日本糖尿病学会年次学術集会
    • Related Report
      2018 Research-status Report
  • [Presentation] オンコスタチンMはSTAT3を介して骨格筋萎縮に関与する2018

    • Author(s)
      三木祐哉,森岡与明,塩井 淳,佐倉剛史,角谷佳則,藤元健太,上殿英記,森 克仁,庄司哲雄,絵本正憲,稲葉雅章
    • Organizer
      第39回日本肥満学会
    • Related Report
      2018 Research-status Report
  • [Presentation] 腎不全に伴うサルコペニアにオンコスタチンMが関与する2018

    • Author(s)
      三木祐哉,森岡与明,塩井 淳,佐倉剛史,角谷佳則,藤元健太,上殿英記,森 克仁,庄司哲雄,絵本正憲,稲葉雅章
    • Organizer
      第5回日本サルコペニア・フレイル学会
    • Related Report
      2018 Research-status Report
  • [Remarks] 教室ホームページ 研究紹介「糖尿病代謝・動脈硬化研究部門」

    • URL

      http://www.med.osaka-cu.ac.jp/interm2/research/diabetes.shtml

    • Related Report
      2021 Annual Research Report

URL: 

Published: 2018-04-23   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi